Pursuant to the Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 and any other applicable provisions, if any, we wish to inform you that a meeting of the Board of Directors of the Company was held today i.e. 29th May, 2023, have inter alia considered, approved and taken on record the Standalone Financial Results of Brawn Biotech Limited for the fourth quarter and financial year ended March 31st 2023, which was recommended by the Audit Committee at their meeting held on 29th May, 2023. Further, pursuant to provisions of Regulation 33 of SEBI Listing Regulations, please find enclosed herewith Standalone Audited Financial Results, along with Auditor's report and declaration on unmodified Audit Report.